Latest On Evofem Biosciences, Inc (EVFM):
About Evofem Biosciences, Inc (EVFM):
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.
General
- Name Evofem Biosciences, Inc
- Symbol EVFM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 147
- Last Split Factor1:6
- Last Split Date2018-01-18
- Fiscal Year EndDecember
- IPO Date2018-01-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Web URLhttp://www.evofem.com
Valuation
- Price/Sales (Trailing 12 Mt.) 432.16
- Price/Book (Most Recent Quarter) 177.1
- Enterprise Value Revenue 617.94
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.57
- Next Year EPS Estimate -$0.96
- Next Quarter EPS Estimate -$0.44
- Operating Margin -23212%
- Return on Assets -94%
- Return on Equity -1676%
- Revenue 446000
- Earnings Per Share -$3.01
- Revenue Per Share $0.01
- Gross Profit 78000
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 226.08 million
- EBITDA -58724000
- Analyst Target Price $7.4
- Book Value Per Share $0.02
Share Statistics
- Shares Outstanding 83.12 million
- Shares Float 80.59 million
- % Held by Insiders 165%
- % Held by Institutions 45%
- Shares Short 9.41 million
- Shares Short Prior Month 9.44 million
- Short Ratio 1.77
- Short % of Float 21%
- Short % of Shares Outstanding 12%
Technicals
- Beta -0.3
- 52 Week High $6.25
- 52 Week Low $1.91
- 50 Day Moving Average 3.43
- 200 Day Moving Average 2.74
Dividends
- Dividend Date 2018-01-18
- ExDividend Date N/A
- Dividend Yield 0%
Evofem Biosciences, Inc (EVFM) Dividend Calendar:
EVFM's last dividend payment was made to shareholders on January 18, 2018.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Evofem Biosciences, Inc (EVFM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-04 | $N/A | -$0.49 | -$0.36 | -35.17% |
2020-09-30 | 2020-11-09 | $N/A | -$0.37 | -$0.44 | 15.91% |
2020-06-30 | 2020-08-04 | $N/A | -$0.91 | -$0.37 | -143.77% |
2020-03-31 | 2020-05-06 | $N/A | -$0.40 | -$0.35 | -15.37% |
2019-12-31 | 2020-03-12 | $N/A | -$0.27 | -$0.30 | 10% |
2019-09-30 | 2019-11-06 | $N/A | -$0.30 | -$0.31 | 2.44% |
2019-06-30 | 2019-08-06 | $N/A | -$0.97 | -$0.36 | -169.44% |
2019-03-31 | 2019-05-07 | $N/A | -$0.67 | -$0.44 | -52.27% |
2018-12-31 | 2019-03-01 | $N/A | -$0.58 | -$0.55 | -5.45% |
2018-09-30 | 2018-11-07 | $N/A | -$0.71 | -$0.42 | -69.05% |
2018-06-30 | 2018-08-02 | $N/A | -$1.11 | -$0.48 | -132.46% |
2018-03-31 | 2018-05-14 | $N/A | -$1.42 | -$0.41 | -245.34% |
2017-12-31 | 2018-02-26 | $N/A | -$1.02 | -$1.14 | 10.32% |
2017-09-30 | 2017-11-08 | $N/A | -$0.78 | ||
2017-06-30 | 2017-08-10 | $N/A | -$1.22 | ||
2017-03-31 | 2017-05-11 | $N/A | -$1.32 | -$1.14 | -15.79% |
2016-12-31 | 2017-03-23 | $N/A | -$0.84 | -$1.20 | 30% |
2016-09-30 | 2016-11-10 | $N/A | -$1.02 | -$1.86 | 45.16% |
2016-06-30 | 2016-08-11 | $N/A | -$1.14 | -$2.40 | 52.5% |
2016-03-31 | 2016-05-12 | $N/A | -$2.63 | ||
2015-12-31 | 2016-03-29 | $N/A | -$0.69 | -$1.14 | 39.47% |
2015-09-30 | 2015-11-12 | $N/A | -$1.26 | -$1.14 | -10.53% |
2015-06-30 | 2015-08-13 | $N/A | -$0.69 | -$1.14 | 39.47% |
2015-03-31 | 2015-05-14 | $N/A | -$0.50 | -$0.93 | 46.24% |
2014-12-31 | 2015-03-26 | -$0.45 | -$0.32 | -40.63% | |
2014-09-30 | 2014-12-01 | -$1.69 |
Evofem Biosciences, Inc (EVFM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Evofem Biosciences, Inc (EVFM) Chart:
Evofem Biosciences, Inc (EVFM) News:
Below you will find a list of latest news for Evofem Biosciences, Inc (EVFM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Evofem Biosciences, Inc (EVFM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest EVFM Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 6:40 PM EST | 100 | $0.3135 |
Jun 13, 2022 6:40 PM EST | 100 | $0.3135 |
Jun 13, 2022 7:45 PM EST | 100 | $0.3183 |
Jun 13, 2022 7:58 PM EST | 100 | $0.3157 |
Jun 13, 2022 7:58 PM EST | 100 | $0.3149 |
Evofem Biosciences, Inc (EVFM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000119312520176540/0001193125-20-176540-index.htm |
2019-05-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1618835/000000000019008039/0000000000-19-008039-index.htm |
2019-06-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1618835/000000000019010506/0000000000-19-010506-index.htm |
2019-11-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1618835/000000000019015862/0000000000-19-015862-index.htm |
2020-03-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000083423720009226/0000834237-20-009226-index.htm |
2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000083423720009560/0000834237-20-009560-index.htm |
2019-04-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000089924319010887/0000899243-19-010887-index.htm |
2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000089924319016240/0000899243-19-016240-index.htm |
2019-10-31 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000089924319026405/0000899243-19-026405-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000089924320014185/0000899243-20-014185-index.htm |
2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000089924320019497/0000899243-20-019497-index.htm |
2020-06-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000090266420002330/0000902664-20-002330-index.htm |
2020-06-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000090266420002334/0000902664-20-002334-index.htm |
2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000090266420002335/0000902664-20-002335-index.htm |
2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000090445419000430/0000904454-19-000430-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000090445419000478/0000904454-19-000478-index.htm |
2019-04-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000091420819000222/0000914208-19-000222-index.htm |
2019-06-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000091420819000317/0000914208-19-000317-index.htm |
2020-06-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000091420820000337/0000914208-20-000337-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000114036120003095/0001140361-20-003095-index.htm |
2019-04-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000119312519110809/0001193125-19-110809-index.htm |
2019-06-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000119312519169440/0001193125-19-169440-index.htm |
2019-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000119312519219124/0001193125-19-219124-index.htm |
2019-10-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000119312519266736/0001193125-19-266736-index.htm |
2019-10-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000119312519277661/0001193125-19-277661-index.htm |
2020-05-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1618835/000119312520151580/0001193125-20-151580-index.htm |
2020-06-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000119312520176540/0001193125-20-176540-index.htm |
2019-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000120919119024559/0001209191-19-024559-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000120919119036289/0001209191-19-036289-index.htm |
2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000120919120035184/0001209191-20-035184-index.htm |
2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390019008221/0001213900-19-008221-index.htm |
2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390019008223/0001213900-19-008223-index.htm |
2019-08-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390019014930/0001213900-19-014930-index.htm |
2019-08-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390019014933/0001213900-19-014933-index.htm |
2019-11-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390019022533/0001213900-19-022533-index.htm |
2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1618835/000121390020002524/0001213900-20-002524-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000017/0001618835-19-000017-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000018/0001618835-19-000018-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000019/0001618835-19-000019-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000020/0001618835-19-000020-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000021/0001618835-19-000021-index.htm |
2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000027/0001618835-19-000027-index.htm |
2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000031/0001618835-19-000031-index.htm |
2019-03-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000038/0001618835-19-000038-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000045/0001618835-19-000045-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000046/0001618835-19-000046-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000047/0001618835-19-000047-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000048/0001618835-19-000048-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000049/0001618835-19-000049-index.htm |
2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000050/0001618835-19-000050-index.htm |
2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000058/0001618835-19-000058-index.htm |
2019-04-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000062/0001618835-19-000062-index.htm |
2019-04-22 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000063/0001618835-19-000063-index.htm |
2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000068/0001618835-19-000068-index.htm |
2019-04-30 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000073/0001618835-19-000073-index.htm |
2019-05-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000075/0001618835-19-000075-index.htm |
2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000084/0001618835-19-000084-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000085/0001618835-19-000085-index.htm |
2019-05-07 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000088/0001618835-19-000088-index.htm |
2019-05-10 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000090/0001618835-19-000090-index.htm |
2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000096/0001618835-19-000096-index.htm |
2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000104/0001618835-19-000104-index.htm |
2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000105/0001618835-19-000105-index.htm |
2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000106/0001618835-19-000106-index.htm |
2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000107/0001618835-19-000107-index.htm |
2019-06-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000109/0001618835-19-000109-index.htm |
2019-06-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000111/0001618835-19-000111-index.htm |
2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000114/0001618835-19-000114-index.htm |
2019-06-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000122/0001618835-19-000122-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000123/0001618835-19-000123-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000124/0001618835-19-000124-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000125/0001618835-19-000125-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000126/0001618835-19-000126-index.htm |
2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000127/0001618835-19-000127-index.htm |
2019-06-24 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000132/0001618835-19-000132-index.htm |
2019-06-24 | RW | Registration Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000133/0001618835-19-000133-index.htm |
2019-06-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000135/0001618835-19-000135-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000138/0001618835-19-000138-index.htm |
2019-07-02 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000139/0001618835-19-000139-index.htm |
2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000141/0001618835-19-000141-index.htm |
2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000144/0001618835-19-000144-index.htm |
2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000147/0001618835-19-000147-index.htm |
2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000153/0001618835-19-000153-index.htm |
2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000154/0001618835-19-000154-index.htm |
2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000155/0001618835-19-000155-index.htm |
2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000156/0001618835-19-000156-index.htm |
2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000157/0001618835-19-000157-index.htm |
2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000160/0001618835-19-000160-index.htm |
2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000167/0001618835-19-000167-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000170/0001618835-19-000170-index.htm |
2019-11-18 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000176/0001618835-19-000176-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000182/0001618835-19-000182-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000183/0001618835-19-000183-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000184/0001618835-19-000184-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000185/0001618835-19-000185-index.htm |
2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000186/0001618835-19-000186-index.htm |
2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000192/0001618835-19-000192-index.htm |
2019-11-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000195/0001618835-19-000195-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000201/0001618835-19-000201-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000202/0001618835-19-000202-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000203/0001618835-19-000203-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000204/0001618835-19-000204-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000205/0001618835-19-000205-index.htm |
2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000208/0001618835-19-000208-index.htm |
2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000212/0001618835-19-000212-index.htm |
2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000213/0001618835-19-000213-index.htm |
2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000214/0001618835-19-000214-index.htm |
2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000217/0001618835-19-000217-index.htm |
2019-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000219/0001618835-19-000219-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000003/0001618835-20-000003-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000004/0001618835-20-000004-index.htm |
2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000007/0001618835-20-000007-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000010/0001618835-20-000010-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000011/0001618835-20-000011-index.htm |
2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000013/0001618835-20-000013-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000019/0001618835-20-000019-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000020/0001618835-20-000020-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000021/0001618835-20-000021-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000022/0001618835-20-000022-index.htm |
2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000023/0001618835-20-000023-index.htm |
2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000027/0001618835-20-000027-index.htm |
2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000028/0001618835-20-000028-index.htm |
2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000033/0001618835-20-000033-index.htm |
2020-02-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000036/0001618835-20-000036-index.htm |
2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000037/0001618835-20-000037-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000045/0001618835-20-000045-index.htm |
2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000047/0001618835-20-000047-index.htm |
2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000050/0001618835-20-000050-index.htm |
2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000052/0001618835-20-000052-index.htm |
2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000057/0001618835-20-000057-index.htm |
2020-03-25 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000059/0001618835-20-000059-index.htm |
2020-03-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000069/0001618835-20-000069-index.htm |
2020-03-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000071/0001618835-20-000071-index.htm |
2020-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000073/0001618835-20-000073-index.htm |
2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000076/0001618835-20-000076-index.htm |
2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000081/0001618835-20-000081-index.htm |
2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000084/0001618835-20-000084-index.htm |
2020-04-28 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000090/0001618835-20-000090-index.htm |
2020-05-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000094/0001618835-20-000094-index.htm |
2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000096/0001618835-20-000096-index.htm |
2020-05-06 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000099/0001618835-20-000099-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000103/0001618835-20-000103-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000105/0001618835-20-000105-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000111/0001618835-20-000111-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000112/0001618835-20-000112-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000113/0001618835-20-000113-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000114/0001618835-20-000114-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000115/0001618835-20-000115-index.htm |
2020-05-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000120/0001618835-20-000120-index.htm |
2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000124/0001618835-20-000124-index.htm |
2020-05-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000126/0001618835-20-000126-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000133/0001618835-20-000133-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000134/0001618835-20-000134-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000135/0001618835-20-000135-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000136/0001618835-20-000136-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000137/0001618835-20-000137-index.htm |
2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000138/0001618835-20-000138-index.htm |
2020-05-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000144/0001618835-20-000144-index.htm |
2020-05-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000146/0001618835-20-000146-index.htm |
2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000149/0001618835-20-000149-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000155/0001618835-20-000155-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000156/0001618835-20-000156-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000157/0001618835-20-000157-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000158/0001618835-20-000158-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000159/0001618835-20-000159-index.htm |
2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000169/0001618835-20-000169-index.htm |
2020-06-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000171/0001618835-20-000171-index.htm |
2020-06-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000176/0001618835-20-000176-index.htm |
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000178/0001618835-20-000178-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000185/0001618835-20-000185-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000186/0001618835-20-000186-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000187/0001618835-20-000187-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000188/0001618835-20-000188-index.htm |
2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000189/0001618835-20-000189-index.htm |
2020-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000192/0001618835-20-000192-index.htm |
2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000194/0001618835-20-000194-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000196/0001618835-20-000196-index.htm |
2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000198/0001618835-20-000198-index.htm |
2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000200/0001618835-20-000200-index.htm |
2020-06-18 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000203/0001618835-20-000203-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000204/0001618835-20-000204-index.htm |
2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000206/0001618835-20-000206-index.htm |
2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000214/0001618835-20-000214-index.htm |
2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000216/0001618835-20-000216-index.htm |
2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000218/0001618835-20-000218-index.htm |
2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000220/0001618835-20-000220-index.htm |
2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000222/0001618835-20-000222-index.htm |
2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000226/0001618835-20-000226-index.htm |
2020-10-16 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000227/0001618835-20-000227-index.htm |
2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000162828019012045/0001628280-19-012045-index.htm |
2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1618835/000162828019012268/0001628280-19-012268-index.htm |
2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1618835/000162828019012348/0001628280-19-012348-index.htm |
2019-05-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1618835/999999999519001037/9999999995-19-001037-index.htm |
2019-07-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1618835/999999999519001523/9999999995-19-001523-index.htm |
2019-12-02 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1618835/999999999519002726/9999999995-19-002726-index.htm |
Evofem Biosciences, Inc (EVFM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Evofem Biosciences, Inc (EVFM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 165%Institutional Ownership: 4500%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-05-21 | Kim P. Kamdar | Director | Sell | 655.00 | 5.07 | 3,320.85 | 0.00 | https://www.sec.gov/Archives/edgar/data/1618835/000090445419000430/0000904454-19-000430-index.htm |
2020-06-04 | RESEARCH CORP ACACIA | 10% Share Holder | Sell | 9,138,504.00 | 3.21 | 29,325,459.34 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1618835/000090266420002335/0000902664-20-002335-index.htm |
2019-02-25 | Alexander A Fitzpatrick | General Counsel and Secretary | Buy | 50,000.00 | 107,623.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000019/0001618835-19-000019-index.htm | ||
2019-06-10 | Ltd. Invesco | 10% Share Holder | Buy | 2,222,222.00 | 4.50 | 9,999,999.00 | 11,812,910.00 | https://www.sec.gov/Archives/edgar/data/1618835/000120919119036289/0001209191-19-036289-index.htm |
2020-05-26 | Ltd. Invesco | 10% Share Holder | Sell | 65.00 | 5.98 | 388.70 | 12,369,389.00 | https://www.sec.gov/Archives/edgar/data/1618835/000120919120035184/0001209191-20-035184-index.htm |
2020-05-26 | Ltd. Invesco | 10% Share Holder | Sell | 73,814.00 | 5.79 | 427,383.06 | 12,369,454.00 | https://www.sec.gov/Archives/edgar/data/1618835/000120919120035184/0001209191-20-035184-index.htm |
2020-05-15 | Ltd. Invesco | 10% Share Holder | Sell | 3,211.00 | 5.04 | 16,183.44 | 12,443,268.00 | https://www.sec.gov/Archives/edgar/data/1618835/000120919120035184/0001209191-20-035184-index.htm |
2020-06-05 | Ltd. Invesco | 10% Share Holder | Buy | 857,143.00 | 3.50 | 3,000,000.50 | 13,226,532.00 | https://www.sec.gov/Archives/edgar/data/1618835/000120919120035184/0001209191-20-035184-index.htm |
2019-06-10 | PDL BIOPHARMA, INC. | 10% Share Holder | Buy | 6,666,667.00 | 4.50 | 30,000,001.50 | 13,333,334.00 | https://www.sec.gov/Archives/edgar/data/1618835/000089924319016240/0000899243-19-016240-index.htm |
2020-01-13 | Justin J. File | Chief Financial Officer | Sell | 1,648.00 | 6.00 | 9,888.00 | 177,251.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000011/0001618835-20-000011-index.htm |
2020-01-02 | Justin J. File | Chief Financial Officer | Sell | 3,352.00 | 6.05 | 20,279.60 | 178,899.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000003/0001618835-20-000003-index.htm |
2020-02-05 | Justin J. File | Chief Financial Officer | Buy | 3,846.00 | 5.21 | 20,037.66 | 181,097.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000020/0001618835-20-000020-index.htm |
2019-12-02 | Justin J. File | Chief Financial Officer | Sell | 10,000.00 | 7.16 | 71,600.00 | 182,251.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000213/0001618835-19-000213-index.htm |
2020-05-01 | Kelly Culwell | Chief Medical Officer | Sell | 1,000.00 | 4.75 | 4,750.00 | 194,226.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000096/0001618835-20-000096-index.htm |
2020-04-30 | Kelly Culwell | Chief Medical Officer | Sell | 1,000.00 | 4.66 | 4,660.00 | 195,226.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000096/0001618835-20-000096-index.htm |
2020-02-19 | Kelly Culwell | Chief Medical Officer | Sell | 1,000.00 | 7.00 | 7,000.00 | 196,226.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000028/0001618835-20-000028-index.htm |
2020-01-16 | Russell Barrans | Chief Commercial Officer | Sell | 1,578.00 | 6.50 | 10,257.00 | 196,298.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000013/0001618835-20-000013-index.htm |
2020-02-05 | Russell Barrans | Chief Commercial Officer | Buy | 899.00 | 5.21 | 4,683.79 | 197,197.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000023/0001618835-20-000023-index.htm |
2020-02-05 | Kelly Culwell | Chief Medical Officer | Buy | 150,000.00 | 197,226.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000019/0001618835-20-000019-index.htm | ||
2019-11-21 | Justin J. File | Chief Financial Officer | Sell | 4,900.00 | 6.00 | 29,400.00 | 202,353.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000183/0001618835-19-000183-index.htm |
2019-11-20 | Justin J. File | Chief Financial Officer | Sell | 100.00 | 6.00 | 600.00 | 207,253.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000183/0001618835-19-000183-index.htm |
2019-06-30 | Thomas G Lynch | Director | Buy | 37,500.00 | 212,500.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000138/0001618835-19-000138-index.htm | ||
2020-02-05 | Alexander A Fitzpatrick | General Counsel and Secretary | Buy | 150,000.00 | 213,331.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000021/0001618835-20-000021-index.htm | ||
2019-07-08 | Russell Barrans | Chief Commercial Officer | Buy | 150,000.00 | 230,416.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000141/0001618835-19-000141-index.htm | ||
2019-02-25 | Justin J. File | Chief Financial Officer | Buy | 50,000.00 | 230,490.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000021/0001618835-19-000021-index.htm | ||
2019-09-30 | Thomas G Lynch | Director | Buy | 37,500.00 | 250,000.00 | https://www.sec.gov/Archives/edgar/data/1618835/000162828019012045/0001628280-19-012045-index.htm | ||
2020-06-12 | Justin J. File | Chief Financial Officer | Buy | 8,500.00 | 3.14 | 26,690.00 | 250,408.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000194/0001618835-20-000194-index.htm |
2020-09-10 | Russell Barrans | Chief Commercial Officer | Buy | 1,000.00 | 2.71 | 2,710.00 | 276,052.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000220/0001618835-20-000220-index.htm |
2020-09-11 | Russell Barrans | Chief Commercial Officer | Buy | 3,000.00 | 2.08 | 6,240.00 | 279,052.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000220/0001618835-20-000220-index.htm |
2019-12-31 | Thomas G Lynch | Director | Buy | 37,500.00 | 287,500.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000219/0001618835-19-000219-index.htm | ||
2020-03-31 | Thomas G Lynch | Director | Buy | 37,500.00 | 325,000.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000073/0001618835-20-000073-index.htm | ||
2020-02-05 | Justin J. File | Chief Financial Officer | Buy | 150,000.00 | 331,097.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000020/0001618835-20-000020-index.htm | ||
2020-02-19 | Russell Barrans | Chief Commercial Officer | Sell | 14,957.00 | 6.50 | 97,220.50 | 332,240.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000027/0001618835-20-000027-index.htm |
2020-02-05 | Russell Barrans | Chief Commercial Officer | Buy | 150,000.00 | 347,197.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000023/0001618835-20-000023-index.htm | ||
2020-09-08 | SAUNDRA L PELLETIER | Chief Executive Officer | Sell | 122,500.00 | 3.26 | 399,350.00 | 360,888.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000218/0001618835-20-000218-index.htm |
2020-01-13 | SAUNDRA L PELLETIER | Chief Executive Officer | Sell | 3,295.00 | 6.00 | 19,770.00 | 362,289.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000010/0001618835-20-000010-index.htm |
2020-01-02 | SAUNDRA L PELLETIER | Chief Executive Officer | Sell | 6,705.00 | 6.05 | 40,565.25 | 365,584.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000004/0001618835-20-000004-index.htm |
2020-02-05 | SAUNDRA L PELLETIER | Chief Executive Officer | Buy | 3,846.00 | 5.21 | 20,037.66 | 366,135.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000022/0001618835-20-000022-index.htm |
2019-12-02 | SAUNDRA L PELLETIER | Chief Executive Officer | Sell | 20,000.00 | 7.30 | 146,000.00 | 372,289.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000212/0001618835-19-000212-index.htm |
2019-11-21 | SAUNDRA L PELLETIER | Chief Executive Officer | Sell | 10,000.00 | 6.01 | 60,100.00 | 414,676.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000184/0001618835-19-000184-index.htm |
2019-12-02 | Kelly Culwell | Chief Medical Officer | Sell | 1,000.00 | 7.35 | 7,350.00 | 43,538.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000214/0001618835-19-000214-index.htm |
2020-02-05 | Kelly Culwell | Chief Medical Officer | Buy | 3,688.00 | 5.21 | 19,214.48 | 47,226.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000019/0001618835-20-000019-index.htm |
2019-02-25 | SAUNDRA L PELLETIER | Chief Executive Officer | Buy | 150,000.00 | 491,813.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000020/0001618835-19-000020-index.htm | ||
2020-06-15 | William Walmsley Hall | Director | Buy | 5,000.00 | 2.85 | 14,250.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000198/0001618835-20-000198-index.htm |
2020-06-17 | Lisa Dale Rarick | Director | Buy | 5,250.00 | 2.99 | 15,697.50 | 5,250.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000204/0001618835-20-000204-index.htm |
2019-02-25 | Kelly Culwell | Chief Medical Officer | Buy | 50,000.00 | 61,985.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000018/0001618835-19-000018-index.htm | ||
2020-02-05 | SAUNDRA L PELLETIER | Chief Executive Officer | Buy | 300,000.00 | 666,135.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000022/0001618835-20-000022-index.htm | ||
2019-02-25 | Russell Barrans | Chief Commercial Officer | Buy | 75,000.00 | 87,541.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883519000017/0001618835-19-000017-index.htm | ||
2020-06-12 | Kim P. Kamdar | Director | Buy | 5,000.00 | 2.94 | 14,700.00 | 9,287.00 | https://www.sec.gov/Archives/edgar/data/1618835/000161883520000196/0001618835-20-000196-index.htm |